- /
- Supported exchanges
- / CO
- / AMBU-B.CO
Ambu A/S (AMBU-B CO) stock market data APIs
Ambu A/S Financial Data Overview
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Ambu A/S (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Ambu A/S data using free add-ons & libraries
Get Ambu A/S Fundamental Data
Ambu A/S Fundamental data includes:
- Net Revenue: 6 037 M
- EBITDA: 928 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 0.52
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ambu A/S News
New
Ambu AS (AMBFF) Q4 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges
This article first appeared on GuruFocus. Organic Revenue Growth: 13.1% for the full year; 10% for Q4. Endoscopy Business Growth: 15.4% for the full year; 12.4% for Q4. Anesthesia and Patient Monitor...
Colon Screening: Global Market Size, Growth Trends and Forecast Report (2025-2033) Featuring Analysis of Olympus, FUJIFILM, Medtronic, Ambu A/S, Bracco and Other Key Players
Company Logo Technological advancements, such as AI integration, enhance diagnostics and patient compliance, are propelling market expansion. Despite challenges like high screening costs and limited ...
Novo Holdings to make changes to its Board of Directors
COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ -- Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of ...
European Stocks That May Be Trading Below Their Estimated Value
As the European markets navigate a mixed landscape, with the pan-European STOXX Europe 600 Index seeing slight gains amid dovish signals from U.S. Federal Reserve officials and easing trade tensions, ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.